Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2252 publications
Quantitative CT Analysis Reveals Stability of RA-ILD in Patients Treated with Pirfenidone: Insights from the TRAIL1 Trial.
Journal: American journal of respiratory and critical care medicine
Published: October 14, 2025
Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis.
Journal: Archives of rheumatology
Published: September 22, 2025
Haematococcus pluvialis alleviates bleomycin-induced pulmonary fibrosis in mice by inhibiting transformation of lung fibroblasts into myofibroblast
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: September 08, 2025
ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease.
Journal: Annals of the rheumatic diseases
Published: September 05, 2025
Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease.
Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025
Buyang Huanwu Decoction targets PPARG/SPP1/CD44 signaling pathway: mechanisms of lipid dysregulation and treatment in idiopathic pulmonary fibrosis
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: September 04, 2025
p53-miR-34a Feedback in Lung Fibroblasts Regulates Antifibrotic Effects of CSP7, Nintedanib and Pirfenidone.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: August 18, 2025
Engineering Injectable Silk Fibroin-Agarose Hydrogels for Localized Sustained Pirfenidone Delivery: Evaluation of Physicochemical Properties and Antifibrotic Efficacy.
Journal: ACS applied bio materials
Published: August 08, 2025
Inhalable nanocapsules for lung delivery of Pirfenidone and Bacterioruberin: Modulating macrophages to target pulmonary fibrosis.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: August 06, 2025
Clinical efficacy and safety evaluation of drug therapies for the treatment of progressive fibrotic-interstitial lung diseases (PF-ILDs): a network meta-analysis of randomized controlled trials.
Journal: Expert review of clinical immunology
Published: August 04, 2025
Last Updated: 10/31/2025